Robert Ticktin
Fortune : 119 421 $ au 31/08/2026
Fortune : 119 421 $ au 31/08/2026
Mr. Robert Ticktin is a COO, Secretary & General Counsel at PMV Pharmaceuticals, Inc. Mr. Ticktin was previously employed as an Associate General Counsel by Tesaro, Inc., a Senior Vice President & General Counsel by EPIRUS Biopharmaceuticals, Inc. /Old/, a Secretary, Senior Vice President & General Counsel by EPIRUS Biopharmaceuticals, Inc., and a Senior Vice President & General Counsel by Zalicus, Inc. He received his undergraduate degree from The Ohio State University and a graduate degree from Fordham University School of Law.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 07/04/2026 | 98 695 ( 0,18 % ) | 119 421 $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| PMV PHARMACEUTICALS, INC. | Directeur des opérations | 01/12/2024 |
| Sociétés | Poste | Fin |
|---|---|---|
| TESARO INC | Corporate Officer/Principal | 01/06/2020 |
EPIRUS Biopharmaceuticals, Inc. /Old/
EPIRUS Biopharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops monoclonal antibodies | Conseiller Juridique Général | 01/08/2016 |
| EPIRUS BIOPHARMACEUTICALS, INC. | Conseiller Juridique Général | - |
Zalicus, Inc.
Zalicus, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops pharmaceutical products for patients suffering from pain and immuno-inflammatory diseases | Conseiller Juridique Général | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 7 |
|---|---|
Tesaro, Inc.
Tesaro, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for cancer patients | Health Technology |
The Ohio State University
The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zalicus, Inc.
Zalicus, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops pharmaceutical products for patients suffering from pain and immuno-inflammatory diseases | Health Technology |
EPIRUS Biopharmaceuticals, Inc. /Old/
EPIRUS Biopharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops monoclonal antibodies | Health Technology |
Fordham University School of Law
Fordham University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EPIRUS Biopharmaceuticals, Inc.
EPIRUS Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes biosimilar monoclonal antibodies | Health Technology |
PMV Pharmaceuticals, Inc.
PMV Pharmaceuticals, Inc. BiotechnologyHealth Technology Engages in discovery and development of small molecule, tumor-agnostic therapies targeting p53 | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national